1996 - Kelly West Award, American Diabetes Association
His main research concerns Diabetes mellitus, Internal medicine, Endocrinology, Type 2 diabetes and Gerontology. Richard F. Hamman has included themes like Body mass index, Randomized controlled trial, Incidence and Weight loss in his Diabetes mellitus study. His work deals with themes such as Metformin, Diabetes risk and Hazard ratio, which intersect with Randomized controlled trial.
His work focuses on many connections between Type 2 diabetes and other disciplines, such as Pregnancy, that overlap with his field of interest in Childhood obesity. His Gerontology research integrates issues from Diabetic retinopathy, Hispanic ethnicity, Research design, Prevalence and Depression. His Impaired glucose tolerance research incorporates themes from Odds ratio and Confidence interval.
His primary areas of investigation include Diabetes mellitus, Internal medicine, Endocrinology, Type 2 diabetes and Gerontology. His work in Diabetes mellitus tackles topics such as Confidence interval which are related to areas like Odds ratio. His research in Body mass index, Insulin, Risk factor, Insulin resistance and Impaired glucose tolerance are components of Internal medicine.
Type 2 diabetes is closely attributed to Metformin in his work. His work carried out in the field of Metformin brings together such families of science as Placebo, Weight loss and Diabetes risk. His Gerontology research is multidisciplinary, incorporating perspectives in Research design, Randomized controlled trial, Epidemiology and Psychological intervention.
His primary areas of study are Diabetes mellitus, Internal medicine, Type 1 diabetes, Type 2 diabetes and Endocrinology. The various areas that Richard F. Hamman examines in his Diabetes mellitus study include Research design, Disease, Pediatrics and Risk factor. In his work, Odds ratio is strongly intertwined with Surgery, which is a subfield of Internal medicine.
His Type 2 diabetes study combines topics in areas such as Observational study, Incidence, Gerontology, Epidemiology and Medical record. The concepts of his Endocrinology study are interwoven with issues in Allele and Confidence interval. His study looks at the relationship between Metformin and fields such as Diabetes risk, as well as how they intersect with chemical problems.
The scientist’s investigation covers issues in Diabetes mellitus, Internal medicine, Type 1 diabetes, Type 2 diabetes and Endocrinology. His Diabetes mellitus study combines topics from a wide range of disciplines, such as Research design, Intensive care medicine, Positive predicative value, Diagnosis code and Etiology. His research in Internal medicine intersects with topics in Physical therapy and Birth weight.
His study in Type 1 diabetes is interdisciplinary in nature, drawing from both Body mass index, Cardiology, Young adult, Arterial stiffness and Disease. His biological study spans a wide range of topics, including Odds ratio, Incidence, Cohort study, Gerontology and Type 2 Diabetes Mellitus. As a part of the same scientific family, he mostly works in the field of Metformin, focusing on Diabetes risk and, on occasion, Genetic risk, Intervention and Placebo.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
W. C. Knowler;E. Barrett-connor;S. E. Fowler;R. F. Hamman.
The New England Journal of Medicine (2002)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W.Y. Yau;Sophie L. Rogers;Ryo Kawasaki;Ecosse L. Lamoureux;Ecosse L. Lamoureux.
Diabetes Care (2012)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C Knowler;Sarah E Fowler;Richard F Hamman.
The Lancet (2009)
Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: A meta-analysis
F.G.R. Fowkes;G.D. Murray;I. Butcher;C.L. Heald.
Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dana Dabelea;Elizabeth Jane Mayer-Davis;Sharon Saydah;Giuseppina Imperatore.
The prevalence of diabetic retinopathy among adults in the United States.
Kempen Jh;O'Colmain Bj;Leske Mc;Haffner Sm.
Archives of Ophthalmology (2004)
Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes
Richard F. Hamman;Rena R. Wing;Sharon L. Edelstein;John M. Lachin.
Diabetes Care (2006)
Adult respiratory distress syndrome: risk with common predispositions.
Alpha A. Fowler;Richard F. Hamman;James T. Good;Kim N. Benson.
Annals of Internal Medicine (1983)
Increasing Prevalence of Gestational Diabetes Mellitus (GDM) Over Time and by Birth Cohort: Kaiser Permanente of Colorado GDM Screening Program
Dana Dabelea;Janet K. Snell-Bergeon;Cynthia L. Hartsfield;Kimberly J. Bischoff.
Diabetes Care (2005)
The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study
Angela D Liese;Ralph B D'Agostino;Richard F Hamman.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: